申请人:——
公开号:US20040077551A1
公开(公告)日:2004-04-22
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
本发明涉及三肽化合物、组合物及治疗丙型肝炎病毒(HCV)感染的方法。特别是,本发明提供了新的三肽类似物、含有这些类似物的药物组合物以及使用这些类似物治疗HCV感染的方法。